Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban in Stable Coronary Artery Disease (ACER)
NCT07853612Phase 4Active, not recruiting
- Sponsor
- The University of the West Indies
- Start
- Sep 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in coronary artery disease (CAD), sponsored by The University of the West Indies. Started Sep 2026; status: active, not recruiting.
02
Drugs
apixaban
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT07853612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07853612.